EXEL

Q: What is the price of Exelixis (EXEL) today?

The price of Exelixis (EXEL) today is $ 43.88, with return of 26.93% compared to the last year. The price of Exelixis (EXEL) started the year trading around $ 43.83 and today it is at $ 43.88. Follow the real-time price chart, the historical price of Exelixis (EXEL) and international markets.

Q: When does Exelixis (EXEL) pay dividends?

Exelixis (EXEL) did not distribute dividends in the last year.

Q: Is Exelixis (EXEL) worth it?

Currently, Exelixis (EXEL) is priced at $ 43.88, with a P/E of 14.91%, representing a deviation of 2,458% from its historical average P/E. In the last year, the stock showed a variation of 26.93 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 26.93%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Exelixis (EXEL) stock?

Investing in stocks of Exelixis (EXEL) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Exelixis (EXEL) yield today?

The yield of Exelixis (EXEL) was 6.30% in the last month, 26.93% in the last year and 88.08% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Exelixis (EXEL) today, the total investment would be $ 4,388.00, based on the current price of $ 43.88.If past performance were to repeat, the return on your investment would be:In 1 year: $ 5,569.69In 5 years: $ 8,252.95In 10 years: $ 4,388.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Exelixis Inc.

Price

$ 43.88

return (12m)

26.93%

p/e

14.91

p/bv

5.40

DIVIDEND YIELD

0.00%

EXEL price

EXEL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment EXEL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.30%

3 months

0.69%

1 year

26.93%

2 years

86.80%

5 years

88.08%

10 years

0.00%

Fundamentals EXEL

review the fundamentals of Exelixis shares

P/E

14.91

Sector: -5.82 Industry: -5.82

P/S (PSR)

5.03

Sector: -4.74 Industry: -4.74

P/BV

5.40

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

27.51%

Sector: -72.38% Industry: -72.38%

ROE

36.21%

Sector: -84.15% Industry: -84.15%

ROIC

53.45%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

33.73%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

96.39%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

38.48%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

12.76

Sector: -5.52 Industry: -5.52

EV/EBIT

13.07

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

4.10

Sector: 1.13 Industry: 1.13

BVPS

8.13

Sector: 1.63 Industry: 1.63

EPS

2.94

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.76

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.24

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

10.09%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

21.30%

Sector: - Industry: -

FAIR VALUE OF Exelixis ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 43.88

Fair Value

$ 0.00

Upside/Downside Return potential.

-47.15%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals EXEL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

EXEL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Exelixis

Exelixis Inc.

Average Investor10 user rating

4.0 (0 people)

United States

32 years

Founded: 1994

2000

Time since IPO - 26 years

773

Employees

The Company Exelixis Inc. (United States), is listed on Nasdaq with a market value of $ 11.67 Billions, having an equity of $ 2.16 Billions.

With a total of 773 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 2.32 Billions, which generated a profit in the amount of $ 782.58 Millions.

As for its main indicators, the Company has a P/E ratio of 14.91, a P/BV ratio of 5.40 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker EXEL.

Market cap

$ 11.67 Billions

Net worth

$ 2.16 Billions

US$ 2,161,320,000.00

Assets

$ 2.84 Billions

US$ 2,844,420,000.00

Total Shares Outstanding

266.00 Millions

266,000,000

Average Daily Trading Volume

$ 2.84 Millions

US$ 2,844,577.82

Sector

Health Care

Industry

Biotechnology

EXEL

EXEL revenue and profits

Financial Results EXEL

DRAG THE FRAME TO SEE MORE DATA

EXEL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Exelixis (EXEL) today?

The price of Exelixis (EXEL) today is $ 43.88, with return of 26.93% compared to the last year. The price of Exelixis (EXEL) started the year trading around $ 43.83 and today it is at $ 43.88. Follow the real-time price chart, the historical price of Exelixis (EXEL) and international markets.

When does Exelixis (EXEL) pay dividends?

Exelixis (EXEL) did not distribute dividends in the last year.

Is Exelixis (EXEL) worth it?

Currently, Exelixis (EXEL) is priced at $ 43.88, with a P/E of 14.91%, representing a deviation of 2,458% from its historical average P/E. In the last year, the stock showed a variation of 26.93 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 26.93%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Exelixis (EXEL) stock?

Investing in stocks of Exelixis (EXEL) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Exelixis (EXEL) yield today?

The yield of Exelixis (EXEL) was 6.30% in the last month, 26.93% in the last year and 88.08% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Exelixis (EXEL) today, the total investment would be $ 4,388.00, based on the current price of $ 43.88.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 5,569.69
In 5 years: $ 8,252.95
In 10 years: $ 4,388.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EXEL

Exelixis Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment EXEL

review the fundamentals of Exelixis shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Exelixis

Exelixis Inc.

United States

32 years

2000

773

PROFIT X PRICE EXEL

Financial Results EXEL

EXEL cash flow

Asset, Revenue and Profit Growth - EXEL

EXEL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions